Utilizing massively parallel CRISPRi assays to investigate persistence during antibiotic exposure
ORAL
Abstract
Bacterial persisters are characterised by a subgroup of cells within a population that have significant tolerance to antibiotics. This tolerance is primarily achieved due to the reduction of cell growth and metabolic activity which allows the bacteria to wait out the stress that would otherwise kill the cell and enabling the population to regrow once the stress is removed. The process has previously been attributed, at least in part, to toxin-antitoxin systems that allow the cell to inactivate itself in a probabilistic manner, however it is still unclear as to the global mechanisms that cause this.
Using our previously developed massively parallel CRISPRi assay[1], we explore the entire Escherichia coli genome identifying genes or operons that both enhance or impair the persistence mechanism. We show that the CRISPRi can replace the function of the toxin-antitoxin systems, inhibiting the cells metabolism and improving survival under certain antibiotics. We also highlight certain genes that are necessary for survival regardless of condition and demonstrate the assay as a rapid testing method for genomic applications.
[1] https://doi.org/10.1073/pnas.1918685117
Using our previously developed massively parallel CRISPRi assay[1], we explore the entire Escherichia coli genome identifying genes or operons that both enhance or impair the persistence mechanism. We show that the CRISPRi can replace the function of the toxin-antitoxin systems, inhibiting the cells metabolism and improving survival under certain antibiotics. We also highlight certain genes that are necessary for survival regardless of condition and demonstrate the assay as a rapid testing method for genomic applications.
[1] https://doi.org/10.1073/pnas.1918685117
–
Presenters
-
Keiran Stevenson
Cornell University
Authors
-
Keiran Stevenson
Cornell University
-
Guillaume Lambert
Cornell University